Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program

While the efficacy of ONC201 needs validation in a controlled randomized clinical trial, our real-life data support a better outcome for patients with thalamic tumors treated with ONC201. We demonstrated furthermore the feasibility of a successful academia-driven compassionate use program.

Authors

Institutions

Publication Details

Journal
European Journal of Cancer
Published
2024-12-11
DOI
https://doi.org/10.1016/j.ejca.2024.115165
Citations
11
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
4.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program

Franck Bourdeaut, Imene Hezam, Isabelle Yoldjian, André Rieutord et al.
11 citations
European Journal of Cancer
Glioma Diagnosis and Treatment
4.82
article

Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program

Franck Bourdeaut, Imene Hezam, Isabelle Yoldjian, André Rieutord, Élodie Vauléon, G. Vassal, Michael Capra, Maxime Annereau, Émilie De Carli, V. Salomon, Daniela Di Carlo, Marc Sanson, Virginie Gandemer, Liora Brunel, Samuel Abbou, S. Jacobs, Marina Vignes, David Guyon, Sarah Dumont, Nicolas Epaillard, Jacques Grill, Lucas Denis, Mehdi Touat, Françoise Duperray, X. Baiao, F. Lemos
article en
11 citations

Abstract

While the efficacy of ONC201 needs validation in a controlled randomized clinical trial, our real-life data support a better outcome for patients with thalamic tumors treated with ONC201. We demonstrated furthermore the feasibility of a successful academia-driven compassionate use program.

European Journal of CancerVol. 216
Centre National de la Recherche Scientifique (FR), University of Padua (IT), Inserm (FR), Duquesne University (US), Université Paris-Saclay (FR), Institut Gustave Roussy (FR), Children's Health Ireland at Crumlin (IE), Centre Hospitalier Universitaire de Lille (FR), Sorbonne Université (FR), Agence Nationale de Sécurité du Médicament et des Produits de Santé (FR), Centre Hospitalier Universitaire d'Angers (FR), Institut de génétique et de développement de Rennes (FR), Institut du Cerveau (FR), Centre Hospitalier Universitaire de Rennes (FR), Prédicteurs moléculaires et nouvelles cibles en oncologie, Université d'Angers (FR), Institut Curie (FR), KU Leuven (BE)
Amsterdam University Medical Centers
Openalex Percentile: Top 4%
Glioma Diagnosis and Treatment
4.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.